Medical specialists from Italy tagged as investigators in clinical trials studying Diffuse Cutaneous Systemic Sclerosis
Total 13 results
-
Armando Gabrielli, MD,professorSeen in:
- Ancona, Università Politecnica delle Marche
Trials:- NCT00428883 (Principal Investigator)
Conditions: -
Carlo Selmi, MDSeen in:
- Lombardia, Rozzano, Istituto Clinico Humanitas
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Carlomaurizio Montecucco, MDSeen in:
- Lombardia, Pavia, Fondazione IRCCS Policlinico San Matteo di Pavia
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Gabriele Valentini, MD,professorSeen in:
- Napoli, Seconda Universita di Napoli
Trials:- NCT00428883 (Principal Investigator)
Conditions: -
Gianfranco Ferraccioli, MD,professorSeen in:
- Roma, Catholic University of the Sacred
Trials:- NCT00428883 (Principal Investigator)
Conditions: -
Lorenzo Dagna, MDSeen in:
- Lombardia, Milano, Ospedale San Raffaele S.r.l. - PPDS
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Luca Quartuccio, MDSeen in:
- Friuli-Venezia Giulia, Udine, Azienda Sanitaria Universitaria Friuli Centrale - PO Universitario Santa Maria della Misericordia
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Marco Matucci Cerinic, MDSeen in:
- Toscana, Firenze, Azienda Ospedaliera Universitaria Careggi
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Marco Matucci-Cerinic, MD,professorSeen in:
- Firenze, Universita Di Firenze
Trials:- NCT00428883 (Principal Investigator)
Conditions: -
Maria Antonietta D'Agostino, MDSeen in:
- Lazio, Roma, Fondazione Policlinico Universitario A Gemelli
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Marta Mosca, MDSeen in:
- Pisa, Azienda Ospedaliero Universitaria Pisana
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Maurizio Cutolo, MDSeen in:
- Liguria, Genova, Ospedale Policlinico San Martino
Trials:- NCT04781543 (Principal Investigator)
Conditions: -
Roberto Giacomelli, MD,professorSeen in:
- Aquila, Università de L'Aquila
Trials:- NCT00428883 (Principal Investigator)
Conditions:
Clinical Trials on Diffuse Cutaneous Systemic Sclerosis
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
AmgenEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicKorea, Republic of, France, United States, Spain, Mexico, Japan, Argentina, Greece, Israel
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic Sclerosis | System; SclerosisUnited States
-
Lawson Health Research InstituteMallinckrodtNot yet recruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Mitsubishi Tanabe Pharma America Inc.CompletedDiffuse Cutaneous Systemic SclerosisSpain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
-
CSL BehringCompletedDiffuse Cutaneous Systemic SclerosisAustralia, Germany, Poland, Italy, United Kingdom
-
Hospital for Special Surgery, New YorkHuman Genome Sciences Inc.CompletedSystemic SclerosisUnited States
-
CSL BehringWithdrawnDiffuse Cutaneous Systemic SclerosisBelgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland